NCT06250946 is a Phase 2 clinical trial of HRS-7535;Placebo in Overweight and Obesity, sponsored by Shandong Suncadia Medicine Co., Ltd..

Who is sponsoring NCT06250946?

NCT06250946 is sponsored by Shandong Suncadia Medicine Co., Ltd..

What drugs are being tested in NCT06250946?

Interventions in NCT06250946: HRS-7535;Placebo, Placebo.

What condition does NCT06250946 study?

NCT06250946 studies Overweight and Obesity.

Is NCT06250946 still recruiting?

NCT06250946 is currently completed. Last updated 13 April 2025.

Last reviewed 2025-04-13 · How we verify

NCT06250946

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy and Safety of HRS-7535 Tablets in Obese Subjects .

Completed Phase 2 Last updated 13 April 2025

What this trial tests

Phase 2 trial testing HRS-7535;Placebo in Overweight and Obesity in 235 participants. Completed in 22 January 2025.

Timeline

23 February 2024

Primary endpoint
22 January 2025

22 January 2025

Quick facts

Lead sponsor	Shandong Suncadia Medicine Co., Ltd.
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	235
Start date	23 February 2024
Primary completion	22 January 2025
Estimated completion	22 January 2025
Sites	1 location across China

Drugs / interventions tested

HRS-7535;Placebo — full drug profile →
Placebo

Conditions studied

Overweight and Obesity — all drugs for Overweight and Obesity →

Sponsor

Shandong Suncadia Medicine Co., Ltd. — full company profile →

Who can join

Adults 18 to 65, any sex, with Overweight and Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this trial is to evaluate the efficacy and safety of HRS-7535 in Chinese Obese Subjects.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy.
Nicze M, Dec A, Borówka M, Krzyżak D, et al · · 2024 · cited 9× · PMID 39125772 · DOI 10.3390/ijms25158202
Small-Molecule GLP-1 Receptor Agonists: A Promising Pharmacological Approach.
Șeremet OC, Pușcașu C, Andrei C, Nițulescu G, et al · · 2025 · cited 1× · PMID 41303737 · DOI 10.3390/medicina61111902

Verify or expand the search:

Other recruiting trials for Overweight and Obesity

Currently open trials in the same condition.

NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07230496 — A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healt · Phase 1 · recruiting
NCT07313761 — A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered · Phase 1 · active not recruiting
NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting

Other Shandong Suncadia Medicine Co., Ltd. trials

Trials by the same sponsor.

NCT07272330 — A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects · Phase 1 · completed
NCT07269756 — A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese · Phase 1 · completed
NCT07229560 — A Trial of Itraconazole Effect on HRS-8080 Pharmacokinetics in Healthy Participants · Phase 1 · completed
NCT07097831 — A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy Subjects · Phase 1 · completed
NCT06961643 — Investigation of Pharmacokinetics and Safety of HRS-7535 in Subjects With Hepatic Impairment and Normal Hepatic Function · Phase 1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06250946 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shandong Suncadia Medicine Co., Ltd.
Last refreshed: 13 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06250946.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing